HTG Molecular Diagnostics, Inc.
Символ: HTGMQ
PNK
0.0015
USDПазарна цена днес
-0.0006
Съотношение P/E
-0.0000
Коефициент PEG
0.00M
MRK Cap
- 0.00%
Доходност на DIV
HTG Molecular Diagnostics, Inc. (HTGMQ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 18.77 | 12.2 | 21.9 | 28.7 | |||||||||||
balance-sheet.row.short-term-investments | 3.57 | 0 | 12.3 | 6.3 | |||||||||||
balance-sheet.row.net-receivables | 2.55 | 1.4 | 2.1 | 1.6 | |||||||||||
balance-sheet.row.inventory | 1.56 | 0.9 | 2 | 1.5 | |||||||||||
balance-sheet.row.other-current-assets | 1.95 | 1.1 | 1.2 | 1.1 | |||||||||||
balance-sheet.row.total-current-assets | 24.84 | 15.7 | 27.2 | 32.9 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 3.03 | 1.6 | 2.5 | 2.2 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-non-current-assets | 0.78 | 0.5 | 0.8 | 0.1 | |||||||||||
balance-sheet.row.total-non-current-assets | 3.8 | 2.1 | 3.3 | 2.3 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 28.64 | 17.8 | 30.5 | 35.2 | |||||||||||
balance-sheet.row.account-payables | 2.25 | 1.2 | 1.6 | 1.3 | |||||||||||
balance-sheet.row.short-term-debt | 7.85 | 4.3 | 5.6 | 3.7 | |||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-debt-total | 0.97 | 0.5 | 6.1 | 8.9 | |||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 1.2 | 0.6 | 2.6 | 2 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 7.95 | 4.1 | 10.1 | 13.5 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 1.93 | 1 | 1.4 | 1.1 | |||||||||||
balance-sheet.row.total-liab | 22.78 | 12.4 | 20.1 | 20.7 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.retained-earnings | -464.91 | -229.9 | -208.3 | -191.2 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0.01 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 470.76 | 235.3 | 218.7 | 205.7 | |||||||||||
balance-sheet.row.total-stockholders-equity | 5.87 | 5.4 | 10.4 | 14.5 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 28.64 | 17.8 | 30.5 | 35.2 | |||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-equity | 5.87 | 5.4 | 10.4 | 14.5 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 28.64 | - | - | - | |||||||||||
Total Investments | 3.57 | 0 | 12.3 | 6.3 | |||||||||||
balance-sheet.row.total-debt | 8.81 | 4.8 | 11.7 | 12.6 | |||||||||||
balance-sheet.row.net-debt | -6.39 | -7.4 | 2.1 | -9.8 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -9.75 | -21.6 | -17.1 | -20.9 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0.19 | 0.6 | 0.7 | 1.3 | |||||||||||
cash-flows.row.deferred-income-tax | 1.44 | 1.1 | -1.4 | 0.7 | |||||||||||
cash-flows.row.stock-based-compensation | 0.28 | 0.8 | 1.4 | 1.8 | |||||||||||
cash-flows.row.change-in-working-capital | 1.01 | -0.1 | -1 | -0.2 | |||||||||||
cash-flows.row.account-receivables | -0.17 | 0.7 | -0.8 | 1.6 | |||||||||||
cash-flows.row.inventory | 0.33 | 0.1 | -1.4 | -0.3 | |||||||||||
cash-flows.row.account-payables | 0.39 | -0.5 | 0.5 | 0 | |||||||||||
cash-flows.row.other-working-capital | 0.47 | -0.4 | 0.7 | -1.5 | |||||||||||
cash-flows.row.other-non-cash-items | 0.45 | 0.8 | 0.9 | 0.9 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -6.39 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.01 | 0 | -0.6 | -0.5 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 0.1 | 0 | 0 | |||||||||||
cash-flows.row.purchases-of-investments | -3.54 | -7.6 | -18.6 | -12.5 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 3.3 | 19.9 | 12.6 | 31.6 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -0.24 | 12.4 | -6.7 | 18.7 | |||||||||||
cash-flows.row.debt-repayment | -2.08 | -7.8 | -0.8 | -3.6 | |||||||||||
cash-flows.row.common-stock-issued | 8.25 | 9 | 10.7 | 7.5 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0.22 | 7.4 | 0.5 | 5.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 6.39 | 8.6 | 10.4 | 9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.03 | 0 | 0 | 0 | |||||||||||
cash-flows.row.net-change-in-cash | -0.22 | 2.6 | -12.8 | 11.5 | |||||||||||
cash-flows.row.cash-at-end-of-period | 18.2 | 12.2 | 9.6 | 22.4 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 18.42 | 9.6 | 22.4 | 10.9 | |||||||||||
cash-flows.row.operating-cash-flow | -6.39 | -18.4 | -16.5 | -16.3 | |||||||||||
cash-flows.row.capital-expenditure | -0.01 | 0 | -0.6 | -0.5 | |||||||||||
cash-flows.row.free-cash-flow | -6.39 | -18.4 | -17.2 | -16.7 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 3.47 | 6.4 | 8.9 | 8.5 | |||||||||||
income-statement-row.row.cost-of-revenue | 3.18 | 4.6 | 4.1 | 4 | |||||||||||
income-statement-row.row.gross-profit | 0.29 | 1.8 | 4.8 | 4.6 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 3.1 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | -0.04 | 0 | -1 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 9.85 | 22.6 | 22.6 | 24.1 | |||||||||||
income-statement-row.row.cost-and-expenses | 13.04 | 27.2 | 26.7 | 28.1 | |||||||||||
income-statement-row.row.interest-income | 0.13 | 0.1 | 0 | 0.3 | |||||||||||
income-statement-row.row.interest-expense | 0.31 | 0.9 | 1.1 | 1 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | -0.04 | 0 | 0.7 | -0.5 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | -0.04 | 0 | -1 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | -0.04 | 0 | 0.7 | -0.5 | |||||||||||
income-statement-row.row.interest-expense | 0.31 | 0.9 | 1.1 | 1 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0.19 | 0.6 | 0.7 | 1.3 | |||||||||||
income-statement-row.row.ebitda-caps | -9.43 | - | - | - | |||||||||||
income-statement-row.row.operating-income | -9.56 | -20.8 | -17.8 | -19.6 | |||||||||||
income-statement-row.row.income-before-tax | -9.74 | -21.6 | -17.1 | -20.9 | |||||||||||
income-statement-row.row.income-tax-expense | 0.01 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.net-income | -9.75 | -21.6 | -17.1 | -20.9 |
Често задавани въпроси
Какво е HTG Molecular Diagnostics, Inc. (HTGMQ) общи активи?
HTG Molecular Diagnostics, Inc. (HTGMQ) общите активи са 17777655.000.
Какъв е годишният приход на предприятието?
Годишните приходи са N/A.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -2.888.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -2.888.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -2.808.
Какъв е общият приход на предприятието?
Общият приход е -2.755.
Каква е HTG Molecular Diagnostics, Inc. (HTGMQ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -21594476.000.
Какъв е общият дълг на фирмата?
Общият дълг е 4833948.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 22623682.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 0.000.